Skip to content

Capturing and monitoring global differences in untreated and treated ESKD, KRT modality, and outcomes

Research output: Contribution to journalReview article

Standard

Capturing and monitoring global differences in untreated and treated ESKD, KRT modality, and outcomes. / Pecoits-Filho, Roberto; Okpechi, Ikechi G; Donner, Jo-Ann; Harris, David C H; Aljubori, Harith M; Bello, Aminu K; Bellorin-Font, Ezequiel; Caskey, Fergus J; Collins, Allan; Cueto-Manzano, Alfonso M; Feehally, John; Goh, Bak Leong; Jager, Kitty J; al., et.

In: Kidney International Supplements, 07.11.2019.

Research output: Contribution to journalReview article

Harvard

Pecoits-Filho, R, Okpechi, IG, Donner, J-A, Harris, DCH, Aljubori, HM, Bello, AK, Bellorin-Font, E, Caskey, FJ, Collins, A, Cueto-Manzano, AM, Feehally, J, Goh, BL, Jager, KJ & al., E 2019, 'Capturing and monitoring global differences in untreated and treated ESKD, KRT modality, and outcomes', Kidney International Supplements.

APA

Pecoits-Filho, R., Okpechi, I. G., Donner, J-A., Harris, D. C. H., Aljubori, H. M., Bello, A. K., ... al., E. (Accepted/In press). Capturing and monitoring global differences in untreated and treated ESKD, KRT modality, and outcomes. Kidney International Supplements.

Vancouver

Pecoits-Filho R, Okpechi IG, Donner J-A, Harris DCH, Aljubori HM, Bello AK et al. Capturing and monitoring global differences in untreated and treated ESKD, KRT modality, and outcomes. Kidney International Supplements. 2019 Nov 7.

Author

Pecoits-Filho, Roberto ; Okpechi, Ikechi G ; Donner, Jo-Ann ; Harris, David C H ; Aljubori, Harith M ; Bello, Aminu K ; Bellorin-Font, Ezequiel ; Caskey, Fergus J ; Collins, Allan ; Cueto-Manzano, Alfonso M ; Feehally, John ; Goh, Bak Leong ; Jager, Kitty J ; al., et. / Capturing and monitoring global differences in untreated and treated ESKD, KRT modality, and outcomes. In: Kidney International Supplements. 2019.

Bibtex

@article{f9ad6a5c331e461f8a036aeb922ef8d3,
title = "Capturing and monitoring global differences in untreated and treated ESKD, KRT modality, and outcomes",
abstract = "A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one half to three quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that more than 3 million people in the world died each year because they could not access KRT. In this article, we discuss the reasons for the differences in treated and untreated ESKD, KRT modalities and outcomes, and present strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.",
keywords = "end-stage kidney disease, global health, health information systems, health services accessibility, registries, kidney replacement therapy",
author = "Roberto Pecoits-Filho and Okpechi, {Ikechi G} and Jo-Ann Donner and Harris, {David C H} and Aljubori, {Harith M} and Bello, {Aminu K} and Ezequiel Bellorin-Font and Caskey, {Fergus J} and Allan Collins and Cueto-Manzano, {Alfonso M} and John Feehally and Goh, {Bak Leong} and Jager, {Kitty J} and et al.",
year = "2019",
month = "11",
day = "7",
language = "English",
journal = "Kidney International Supplements",
issn = "2157-1716",

}

RIS - suitable for import to EndNote

TY - JOUR

T1 - Capturing and monitoring global differences in untreated and treated ESKD, KRT modality, and outcomes

AU - Pecoits-Filho, Roberto

AU - Okpechi, Ikechi G

AU - Donner, Jo-Ann

AU - Harris, David C H

AU - Aljubori, Harith M

AU - Bello, Aminu K

AU - Bellorin-Font, Ezequiel

AU - Caskey, Fergus J

AU - Collins, Allan

AU - Cueto-Manzano, Alfonso M

AU - Feehally, John

AU - Goh, Bak Leong

AU - Jager, Kitty J

AU - al., et

PY - 2019/11/7

Y1 - 2019/11/7

N2 - A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one half to three quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that more than 3 million people in the world died each year because they could not access KRT. In this article, we discuss the reasons for the differences in treated and untreated ESKD, KRT modalities and outcomes, and present strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.

AB - A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one half to three quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that more than 3 million people in the world died each year because they could not access KRT. In this article, we discuss the reasons for the differences in treated and untreated ESKD, KRT modalities and outcomes, and present strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.

KW - end-stage kidney disease

KW - global health

KW - health information systems

KW - health services accessibility

KW - registries

KW - kidney replacement therapy

M3 - Review article

JO - Kidney International Supplements

JF - Kidney International Supplements

SN - 2157-1716

ER -